首页> 外国专利> Oral preparation of glucokinase activator and method for producing the same

Oral preparation of glucokinase activator and method for producing the same

机译:葡萄糖激酶激活剂的口服制剂及其生产方法

摘要

The present invention relates to a solid dispersion containing a glucokinase activator, an isotope-labeled product thereof or a pharmaceutically acceptable salt thereof, and a polymer carrier, and a method for producing the same. Further, the present invention relates to a solid dispersion composition containing the solid dispersion and an excipient. The present invention also relates to an oral formulation of a glucokinase activator containing the solid dispersion or solid dispersion composition. The present invention also relates to glucokinase activator tablets, capsules, and methods for producing the same. The present invention also provides a solid dispersion for the treatment and / or prevention of one or more diseases and diseases selected from the group consisting of type I diabetes, type II diabetes, impaired glucose tolerance, impaired fasting glucose, and hyperglycemia. Use of the body, solid dispersion compositions, and oral formulations including tablets and capsules. [Selection diagram] Fig. 6
机译:固体分散体及其制造方法本发明涉及一种固体分散体及其制造方法,所述固体分散体含有葡糖激酶活化剂,其同位素标记产物或其药学上可接受的盐,以及聚合物载体。此外,本发明涉及包含固体分散体和赋形剂的固体分散体组合物。本发明还涉及包含固体分散体或固体分散体组合物的葡萄糖激酶活化剂的口服制剂。本发明还涉及葡糖激酶活化剂片剂,胶囊剂及其生产方法。本发明还提供了用于治疗和/或预防一种或多种疾病的固体分散体,所述疾病选自I型糖尿病,II型糖尿病,葡萄糖耐量降低,空腹血糖受损和高血糖症。身体,固体分散体组合物和口服制剂(包括片剂和胶囊剂)的用途。 [选择图]图6

著录项

  • 公开/公告号JP2020511522A

    专利类型

  • 公开/公告日2020-04-16

    原文格式PDF

  • 申请/专利权人 華領医薬技術(上海)有限公司;

    申请/专利号JP20190553613

  • 发明设计人 陳 力;李 永国;王 高森;

    申请日2017-12-14

  • 分类号A61K31/415;A61K47/32;A61K47/38;A61K47/12;A61K9/20;A61K47/26;A61K9/36;A61K9/48;A61P3/10;

  • 国家 JP

  • 入库时间 2022-08-21 11:34:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号